
{{header
 | title      = To provide for the establishment of the Tick-Borne Diseases Advisory Committee. ( HR610 ; 113th Congress)
 | author     = Mr. Smith of New
			 Jersey
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2013
 | month      = 02
 | day        = 12
 | notes      = ''{{USBill|113|hr|610}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 1
 | title      = To provide for the establishment of the Tick-Borne Diseases Advisory Committee. ( HR610 ; 113th Congress)
 | bill       = 610
 | billtype   = hr
 | purpose    = To provide for the establishment of the Tick-Borne Diseases Advisory Committee.
 | wikipedia  =
}}


{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|H. R. 610}}


{{Center|IN THE HOUSE OF REPRESENTATIVES}}


{{Center|February 12, 2013}}


{{Center|
[[w:Chris Smith (New Jersey politician)|Mr. Smith of New Jersey]] (for himself,
[[w:Frank Wolf|Mr. Wolf]] ,
[[w:Chris Gibson (New York politician)|Mr. Gibson]] , and
[[w:Collin Peterson|Mr. Peterson]] ) introduced the following bill; which was referred to the [[w:United States House Committee on Energy and Commerce|Committee on Energy and Commerce]] }}


{{Center|A BILL}}

To provide for the establishment of the Tick-Borne Diseases Advisory Committee.

=Section 1. Establishment of a tick-borne diseases advisory committee=



==(a) Establishment– ==

Not later than 180 days after the date of the enactment of this Act, the [[w:Department of Health and Human Services|Secretary of Health and Human Services]] (referred to in this Act as the“Secretary”) shall establish within the [[w:|Office of the Secretary]] an advisory committee to be known as the [[w:|Tick-Borne Diseases Advisory Committee]] (referred to in this section as the“Committee”).

==(b) Duties– ==

The [[w:|Committee]] shall advise the [[w:Department of Health and Human Services|Secretary]] and the [[w:Surgeon General of the United States|Assistant Secretary for Health]] regarding the manner in which such officials can—
:(1) ensure interagency coordination and communication and minimize overlap regarding efforts to address tick-borne diseases;
:(2) identify opportunities to coordinate efforts with other Federal agencies and private organizations addressing such diseases;
:(3) ensure interagency coordination and communication with constituency groups;
:(4) ensure that a broad spectrum of scientific viewpoints is represented in public health policy decisions and that information disseminated to the public and physicians is balanced; and
:(5) advise relevant Federal agencies on priorities related to the Lyme and tick-borne diseases.

==(c) Membership– ==



===(1) Appointed members– ===



====(A) In general– ====

The [[w:Department of Health and Human Services|Secretary]] shall appoint the voting members of the [[w:|Committee]] from among individuals who are not officers or employees of the Federal Government.

====(B) Groups– ====

The voting members of the [[w:|Committee]] shall include the following:
:(i) At least 4 members from the scientific community representing the broad spectrum of viewpoints held within the scientific community related to Lyme and other tick-borne diseases.
:(ii) At least 2 representatives of tick-borne disease voluntary organizations.
:(iii) At least 2 health care providers, including at least 1 full-time practicing physician, with relevant experience providing care for individuals with a broad range of acute and chronic tick-borne diseases.
:(iv) At least 2 patient representatives who are individuals who have been diagnosed with a tick-borne disease or who have had an immediate family member diagnosed with such a disease.
:(v) At least 2 representatives of State and local health departments and national organizations that represent State and local health professionals.

====(C) Diversity– ====

In appointing members under this paragraph, the [[w:Department of Health and Human Services|Secretary]] shall ensure that such members, as a group, represent a diversity of scientific perspectives relevant to the duties of the [[w:|Committee]] .

===(2) Ex officio members– ===

The [[w:Department of Health and Human Services|Secretary]] shall designate, as nonvoting, ex officio members of the [[w:|Committee]] , representatives overseeing tick-borne disease activities from each of the following Federal agencies:
:(A) The [[w:Centers for Disease Control and Prevention|Centers for Disease Control and Prevention]] .
:(B) The [[w:National Institutes of Health|National Institutes of Health]] .
:(C) The [[w:Agency for Healthcare Research and Quality|Agency for Healthcare Research and Quality]] .
:(D) The [[w:Food and Drug Administration|Food and Drug Administration]] .
:(E) The [[w:Surgeon General of the United States|Office of the Assistant Secretary for Health]] .
:(F) Such additional Federal agencies as the [[w:Department of Health and Human Services|Secretary]] determines to be appropriate.

===(3) Co-chairpersons– ===

The [[w:Department of Health and Human Services|Secretary]] shall designate the [[w:Surgeon General of the United States|Assistant Secretary for Health]] as the co-chairperson of the [[w:|Committee]] . The appointed members of the [[w:|Committee]] shall also elect a public co-chairperson. The public co-chairperson shall serve a 2-year term.

===(4) Term of appointment– ===

The term of service for each member of the [[w:|Committee]] appointed under paragraph (1)shall be 4 years.

===(5) Vacancy– ===

A vacancy in the membership of the [[w:|Committee]] shall be filled in the same manner as the original appointment. Any member appointed to fill a vacancy for an unexpired term shall be appointed for the remainder of that term. Members may serve after the expiration of their terms until their successors have taken office.

==(d) Meetings– ==

The [[w:|Committee]] shall hold public meetings, except as otherwise determined by the [[w:Department of Health and Human Services|Secretary]] , after providing notice to the public of such meetings, and shall meet at least twice a year with additional meetings subject to the call of the co-chairpersons. Agenda items with respect to such meetings may be added at the request of the members of the [[w:|Committee]] , including the co-chairpersons. Meetings shall be conducted, and records of the proceedings shall be maintained, as required by applicable law and by regulations of the Secretary.

==(e) Report– ==

Not later than 1 year after the date of the enactment of this Act, and annually thereafter, the [[w:|Committee]] , through the [[w:Centers for Disease Control and Prevention|Director of the Centers for Disease Control]] and Prevention and the [[w:National Institutes of Health|Director of the National Institutes of Health]] , shall submit a report to the [[w:Department of Health and Human Services|Secretary]] . Each such report shall contain, at a minimum—
:(1) a description of the [[w:|Committee’s]] functions;
:(2) a list of the [[w:|Committee’s]] members and their affiliations; and
:(3) a summary of the [[w:|Committee’s]] activities and recommendations during the previous year, including any significant issues regarding the functioning of the [[w:|Committee]] .

==(f) Authorization of Appropriations– ==

Of the amounts made available to the [[w:Department of Health and Human Services|Department of Health and Human Services]] for general departmental management forfiscal years 2013 through 2017, there is authorized to be appropriated $250,000 for each of such fiscal yearsto carry out this Act.Amounts made available to carry out this Act shall be used for the expenses and per diem costs incurred by the [[w:|Committee]] under this section in accordance with the Federal Advisory Committee Act, except that no voting member of the [[w:|Committee]] shall be a permanent salaried employee.
{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
